Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
8.36
+0.24 (2.89%)
At close: Jan 26, 2026, 4:00 PM EST
8.39
+0.04 (0.42%)
After-hours: Jan 26, 2026, 4:10 PM EST
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $51.41 million as of January 26, 2026. Its market cap has decreased by -63.92% in one year.
Market Cap
51.41M
Enterprise Value
-41.40M
1-Year Change
-63.92%
Ranking
Category
Stock Price
$8.36
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $51.41M, a decrease of -90.71%. That is a compound annual growth rate of -36.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 51.63M | -9.98% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 51.98M |
| NeurAxis | 51.77M |
| OS Therapies | 51.77M |
| iBio, Inc. | 50.60M |
| Impact BioMedical | 49.36M |
| CEL-SCI | 49.02M |
| ABVC BioPharma | 48.56M |
| Instil Bio | 48.42M |